Next 10 |
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will participate in two upcoming investor conferences. Details for th...
2024-05-16 11:52:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips AIM ImmunoTech (NYSEMKT: AIM ) just reported results for the first quarter of 2024. AIM ImmunoTech reported earnings per share of -12 cents. This was below the analyst est...
2024-05-16 11:24:09 ET AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Conference Call May 16, 2024 08:30 AM ET Company Participants Thomas Equels - CEO Christopher McAleer - Scientific Officer Conference Call Participants James Molloy - Alliance Global Partne...
2024-05-16 07:33:17 ET More on AIM ImmunoTech AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on AIM ImmunoTech Historical earnings data for AIM ImmunoTech Financial information for AIM ImmunoTech Read ...
Continued execution across Ampligen ® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May 16, at 8:30 AM ET OCALA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech...
2024-05-15 11:47:59 ET Major earnings expected before the bell on Thursday include: Baidu ( BIDU ) Deere & Co. ( DE ) JD.com( JD ) Under Armour ( UAA ) Walmart ( WMT ) Other earnings slated for release before Thursday's open include: ...
2024-05-15 11:26:43 ET More on AIM ImmunoTech AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on AIM ImmunoTech Historical earnings data for AIM ImmunoTech Financial information for AIM ImmunoTech Read ...
OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to discuss the Company’s Q1 2024 operational and financial res...
OCALA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the successfully completion of cGMP manufacturing of 9,042 clinical vials of Ampligen ® (rintatolimod), AIM’s...
OCALA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has taken an essential step forward in testing the combination of AIM’s Ampligen® (rintatolimod) and AstraZ...
News, Short Squeeze, Breakout and More Instantly...
AIM ImmunoTech Inc. Company Name:
AIM Stock Symbol:
NYSE Market:
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that AIM Chief Executive ...
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will participate in two upcoming investor conferences. Details for th...